Literature DB >> 33011973

Photodestruction of Stromal Fibroblasts Enhances Tumor Response to PDT in 3D Pancreatic Cancer Coculture Models.

Vida Karimnia1, Imran Rizvi2,3,4, Frank J Slack5, Jonathan P Celli1.   

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is among the most lethal of human cancers. The dismal response of PDAC to virtually all therapeutics is associated, in part, with a characteristically dense fibrotic stroma. This stroma not only acts as a barrier to drug perfusion, but also promotes tumor survival through paracrine crosstalk and biophysical interactions. Photodynamic therapy (PDT) is being explored for PDAC treatment, though the impact of tumor-promoting stromal crosstalk on PDT response in PDAC is not well-characterized. The current study assesses the effect of tumor-stroma interactions on response to PDT or chemotherapy in heterocellular 3D cocultures using PDAC cells and two different fibroblastic cell types (pancreatic stellate cells, PSCs, and a normal human fibroblast cell line, MRC5) embedded in extracellular matrix (ECM). While stromal fibroblasts promote resistance to chemotherapy as expected, PDAC 3D nodules in coculture with fibroblasts exhibit increased response to PDT relative to homotypic cultures. These results point to the potential for PDT to overcome tumor-promoting stromal interactions associated with poor therapeutic response in PDAC.
© 2020 American Society for Photobiology.

Entities:  

Mesh:

Year:  2020        PMID: 33011973      PMCID: PMC7965253          DOI: 10.1111/php.13339

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  45 in total

Review 1.  Preclinical models of pancreatic ductal adenocarcinoma.

Authors:  Benjamin D Krempley; Kenneth H Yu
Journal:  Chin Clin Oncol       Date:  2017-06

Review 2.  Bystander effects and radiotherapy.

Authors:  Alicia Marín; Margarita Martín; Olga Liñán; Felipe Alvarenga; Mario López; Laura Fernández; David Büchser; Laura Cerezo
Journal:  Rep Pract Oncol Radiother       Date:  2014-08-28

Review 3.  An update on photodynamic therapy applications.

Authors:  Thomas J Dougherty
Journal:  J Clin Laser Med Surg       Date:  2002-02

Review 4.  Photodynamic therapy for pancreatic and biliary tract carcinoma.

Authors:  Lakshmana Ayaru; Stephen G Bown; Stephen P Pereira
Journal:  Int J Gastrointest Cancer       Date:  2005

5.  Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines.

Authors:  Jonathan P Celli; Nicolas Solban; Alvin Liang; Stephen P Pereira; Tayyaba Hasan
Journal:  Lasers Surg Med       Date:  2011-09       Impact factor: 4.025

Review 6.  Tumour-microenvironment interactions: role of tumour stroma and proteins produced by cancer-associated fibroblasts in chemotherapy response.

Authors:  Matthew David Hale; Jeremy David Hayden; Heike Irmgard Grabsch
Journal:  Cell Oncol (Dordr)       Date:  2013-03-14       Impact factor: 6.730

7.  Generation of an in vitro 3D PDAC stroma rich spheroid model.

Authors:  Matthew J Ware; Vazrik Keshishian; Justin J Law; Jason C Ho; Carlos A Favela; Paul Rees; Billie Smith; Sayeeduddin Mohammad; Rosa F Hwang; Kimal Rajapakshe; Cristian Coarfa; Shixia Huang; Dean P Edwards; Stuart J Corr; Biana Godin; Steven A Curley
Journal:  Biomaterials       Date:  2016-09-02       Impact factor: 12.479

8.  Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B.

Authors:  Yu Sun; Judith Campisi; Celestia Higano; Tomasz M Beer; Peggy Porter; Ilsa Coleman; Lawrence True; Peter S Nelson
Journal:  Nat Med       Date:  2012-09       Impact factor: 53.440

9.  Sonic-hedgehog pathway inhibition normalizes desmoplastic tumor microenvironment to improve chemo- and nanotherapy.

Authors:  Fotios Mpekris; Panagiotis Papageorgis; Christiana Polydorou; Chrysovalantis Voutouri; Maria Kalli; Athanassios P Pirentis; Triantafyllos Stylianopoulos
Journal:  J Control Release       Date:  2017-06-27       Impact factor: 9.776

10.  TP63-Mediated Enhancer Reprogramming Drives the Squamous Subtype of Pancreatic Ductal Adenocarcinoma.

Authors:  Tim D D Somerville; Yali Xu; Koji Miyabayashi; Hervé Tiriac; Cristian R Cleary; Diogo Maia-Silva; Joseph P Milazzo; David A Tuveson; Christopher R Vakoc
Journal:  Cell Rep       Date:  2018-11-13       Impact factor: 9.995

View more
  3 in total

Review 1.  Photodynamic Therapy for Pancreatic Ductal Adenocarcinoma.

Authors:  Vida Karimnia; Frank J Slack; Jonathan P Celli
Journal:  Cancers (Basel)       Date:  2021-08-28       Impact factor: 6.575

Review 2.  Tissue Engineering and Photodynamic Therapy: A New Frontier of Science for Clinical Application -An Up-To-Date Review.

Authors:  Mariza Aires-Fernandes; Camila Fernanda Amantino; Stéphanie Rochetti do Amaral; Fernando Lucas Primo
Journal:  Front Bioeng Biotechnol       Date:  2022-06-15

3.  Immune checkpoint blockade enhances chemophototherapy in a syngeneic pancreatic tumor model.

Authors:  Sanjana Ghosh; Xuedan He; Wei-Chiao Huang; Jonathan F Lovell
Journal:  APL Bioeng       Date:  2022-09-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.